# Accent Therapeutics

**Canonical:** https://apis.io/providers/accent-therapeutics/  
**Website:** https://accenttx.com  
**APIs profiled:** 0

Accent Therapeutics is a clinical-stage biopharmaceutical company pioneering a new class of small-molecule precision cancer therapies that target critical intracellular dependencies spanning multiple types of cancer. Its pipeline is led by ATX-295, a novel KIF18A inhibitor in clinical development, with data presented at AACR and ASCO. Backed by GV, Accent focuses on precision oncology drug discovery and development. The company does not currently publish a public developer API; this profile captures its corporate and web identity in the API Evangelist network.

## Kin Score — 9.5 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 9.5).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Accent Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Life Sciences, Biotechnology, Pharmaceuticals, Oncology, Precision Medicine, Drug Discovery

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/accent-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.